Tumor hypoxia in pelvic recurrences of cervical cancer
✍ Scribed by Michael Höckel; Karlheinz Schlenger; Susanne Höckel; Billur Aral; Uwe Schäffer; Peter Vaupel
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- French
- Weight
- 114 KB
- Volume
- 79
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
We have previously demonstrated in primary cancer of the uterine cervix that tumor hypoxia, as determined polarographically, is strongly associated with clinical malignant progression of the disease. Having applied a similar methodological approach to investigate loco-regional relapses, we found a pronounced shift to more hypoxic oxygenation profiles in the recurrent tumors than in the primary tumors. Median pO 2 values in 53 pelvic recurrences were significantly lower than the median pO 2 values of 117 primary tumors of comparable sizes (7.1 ؎ 1.1 mmHg vs. 12.1 ؎ 1.0 mmHg, p ؍ 0.0013). The differences in tumor oxygenation between primary and recurrent tumors mirrored the differences in the patients' 5-year survival probabilities. In the cohort of patients with pelvic relapses, median tumor pO 2 F 4 mmHg indicated a significantly shorter median survival time as compared to median tumor pO 2 H 4 mmHg. Our results further support our thesis that in cervical cancer, tumor hypoxia and clinical aggressiveness in terms of resistance to therapy and tumor dissemination, are interrelated.
📜 SIMILAR VOLUMES
Locally recurrent cancer of the rectum has been under-recognized as a complication, although it affects up to 40% of patients treated with surgery alone. Even in the best centers, rates average 25%. While radiotherapy may reduce recurrence, it is now apparent that total mesorectal excision is the mo
Since the early 1940s, the incidence of cervical cancer has dramatically decreased due in large part to the work of Papanicolaou and Traut. Successful treatment can now be done using simple or radical surgical intervention for early invasive lesions and radiation therapy for more advanced lesions. H